Literature DB >> 11916839

Long time dynamics of Met-enkephalin: comparison of explicit and implicit solvent models.

Min-yi Shen My1, Karl F Freed.   

Abstract

Met-enkephalin is one of the smallest opiate peptides. Yet, its dynamical structure and receptor docking mechanism are still not well understood. The conformational dynamics of this neuron peptide in liquid water are studied here by using all-atom molecular dynamics (MD) and implicit water Langevin dynamics (LD) simulations with AMBER potential functions and the three-site transferable intermolecular potential (TIP3P) model for water. To achieve the same simulation length in physical time, the full MD simulations require 200 times as much CPU time as the implicit water LD simulations. The solvent hydrophobicity and dielectric behavior are treated in the implicit solvent LD simulations by using a macroscopic solvation potential, a single dielectric constant, and atomic friction coefficients computed using the accessible surface area method with the TIP3P model water viscosity as determined here from MD simulations for pure TIP3P water. Both the local and the global dynamics obtained from the implicit solvent LD simulations agree very well with those from the explicit solvent MD simulations. The simulations provide insights into the conformational restrictions that are associated with the bioactivity of the opiate peptide dermorphin for the delta-receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916839      PMCID: PMC1301977          DOI: 10.1016/s0006-3495(02)75530-6

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  20 in total

1.  Study of the electrostatics treatment in molecular dynamics simulations.

Authors:  R Garemyr; A Elofsson
Journal:  Proteins       Date:  1999-11-15

2.  Amyloid fibrils from muscle myoglobin.

Authors:  M Fändrich; M A Fletcher; C M Dobson
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

3.  Pathways to a protein folding intermediate observed in a 1-microsecond simulation in aqueous solution.

Authors:  Y Duan; P A Kollman
Journal:  Science       Date:  1998-10-23       Impact factor: 47.728

4.  Conformation of [Leu5]enkephalin from X-ray diffraction: features important for recognition at opiate receptor.

Authors:  D Smith; J F Griffin
Journal:  Science       Date:  1978-03-17       Impact factor: 47.728

5.  Conformation of Met5-enkephalin determined by high field PMR spectroscopy.

Authors:  B P Roques; C Garbay-Jaureguiberry; R Oberlin; M Anteunis; A K Lala
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

Review 6.  Areas, volumes, packing and protein structure.

Authors:  F M Richards
Journal:  Annu Rev Biophys Bioeng       Date:  1977

7.  Conformational restriction of Tyr and Phe side chains in opioid peptides: information about preferred and bioactive side-chain topology.

Authors:  D Tourwé; K Verschueren; A Frycia; P Davis; F Porreca; V J Hruby; G Toth; H Jaspers; P Verheyden; G Van Binst
Journal:  Biopolymers       Date:  1996-01       Impact factor: 2.505

8.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

9.  Role of membrane lipids in peptide hormone function: binding of enkephalins to micelles.

Authors:  C M Deber; B A Behnam
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Enkephalin: conformational analysis by means of empirical energy calculations.

Authors:  Y Isogai; G Némethy; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

View more
  31 in total

1.  Posttransition state desolvation of the hydrophobic core of the src-SH3 protein domain.

Authors:  Weihua Guo; Sotiria Lampoudi; Joan-Emma Shea
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

2.  Simulations of the role of water in the protein-folding mechanism.

Authors:  Young Min Rhee; Eric J Sorin; Guha Jayachandran; Erik Lindahl; Vijay S Pande
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-16       Impact factor: 11.205

3.  A multidimensional 1H NMR investigation of the conformation of methionine-enkephalin in fast-tumbling bicelles.

Authors:  Isabelle Marcotte; Frances Separovic; Michèle Auger; Stéphane M Gagné
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

4.  Simulation of the folding equilibrium of alpha-helical peptides: a comparison of the generalized Born approximation with explicit solvent.

Authors:  Hugh Nymeyer; Angel E García
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

5.  Kinetic pathways of beta-hairpin (un)folding in explicit solvent.

Authors:  Peter G Bolhuis
Journal:  Biophys J       Date:  2004-10-29       Impact factor: 4.033

6.  Conformational study of Met-enkephalin based on the ECEPP force fields.

Authors:  Lixin Zhan; Jeff Z Y Chen; Wing-Ki Liu
Journal:  Biophys J       Date:  2006-07-07       Impact factor: 4.033

7.  Ensemble-based convergence analysis of biomolecular trajectories.

Authors:  Edward Lyman; Daniel M Zuckerman
Journal:  Biophys J       Date:  2006-04-14       Impact factor: 4.033

Review 8.  Protein-solvent interactions.

Authors:  Ninad Prabhu; Kim Sharp
Journal:  Chem Rev       Date:  2006-05       Impact factor: 60.622

9.  Theoretical investigation of the photoinitiated folding of HP-36.

Authors:  Soonmin Jang; Narasimha Sreerama; Vivian H-C Liao; S Hsiu-Feng Lu; Feng-Yin Li; Seokmin Shin; Robert W Woody; Sheng Hsien Lin
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

10.  Conformational stability and three-dimensional model of the delta-opioid pharmacophore for the extended antiparallel dimer structure of Met-enkephalin in water.

Authors:  Yng-Ching Wu; Jin-Yuan Hsieh; Hong-Chang Lin; Chi-Chuan Hwang
Journal:  J Mol Model       Date:  2006-09-14       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.